Management Board meeting: 14-15 December 2022
Date:
14/12/2022 to 15/12/2022
Location:
European Medicines Agency, Amsterdam, the Netherlands
The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency's performance.
-
List item
Agenda for the 118th meeting of the Management Board: 14-15 December 2022 (PDF/135.26 KB)
Adopted
First published: 14/12/2022
Last updated: 15/12/2022
EMA/MB/817029/20222 -
List item
Minutes of the 118th meeting of the Management Board: 14-15 December 2022 (PDF/251.92 KB)
Adopted
First published: 11/05/2023
EMA/MB/17597/2023 -
List item
Outcome of written procedures finalised during the period from 30 September 2022 to 5 December 2022 (PDF/137.86 KB)
First published: 05/01/2023
EMA/MB/794683/2022 -
List item
Policy 44: European Medicines Agency policy on the handling of competing interests of scientific committees’ members and experts - As adopted by EMA Management Board on 14-15 December 2022 (PDF/870.19 KB)
Adopted
First published: 04/01/2023
Legal effective date: 01/01/2023
EMA/MB/89351/2020 Rev.3 -
List item
Policy 58: European Medicines Agency policy on the handling of competing interests of Management Board members - As adopted by EMA Management Board on 14-15 December 2022 (PDF/222.1 KB)
Adopted
First published: 04/01/2023
Legal effective date: 01/01/2023
EMA/MB/89374/2020 Rev.1 -
List item
European Medicines Agency breach of trust procedure on declarations of competing interests for Management Board members - As adopted by EMA Management Board on 14-15 December 2022 (PDF/136.84 KB)
Adopted
First published: 04/01/2023
EMA/MB/309079/2012 Rev.3 -
List item
European Medicines Agency breach of trust procedure for competing interests of and disclosure of confidential information by scientific committees’ members and experts - As adopted by EMA Management Board on 14-15 December 2022 (PDF/138.38 KB)
Adopted
First published: 04/01/2023
EMA/154320/2012 Rev.3